African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker ; volume:18 ; number:1 ; day:10 ; month:4 ; year:2019 ; pages:1-11 ; date:12.2019
Malaria journal ; 18, Heft 1 (10.4.2019), 1-11, 12.2019
- Urheber
-
Leroy, Didier
Macintyre, Fiona
Adoke, Yeka
Ouoba, Serge
Barry, Aissata
Mombo-Ngoma, Ghyslain
Ndong Ngomo, Jacques Mari
Varo, Rosauro
Dossou, Yannelle
Tshefu, Antoinette Kitoto
Duong, Tran Thanh
Phuc, Bui Quang
Laurijssens, Bart
Klopper, Roland
Khim, Nimol
Legrand, Eric
Ménard, Didier
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12936-019-2756-4
- URN
-
urn:nbn:de:101:1-2019042818542750337946
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Leroy, Didier
- Macintyre, Fiona
- Adoke, Yeka
- Ouoba, Serge
- Barry, Aissata
- Mombo-Ngoma, Ghyslain
- Ndong Ngomo, Jacques Mari
- Varo, Rosauro
- Dossou, Yannelle
- Tshefu, Antoinette Kitoto
- Duong, Tran Thanh
- Phuc, Bui Quang
- Laurijssens, Bart
- Klopper, Roland
- Khim, Nimol
- Legrand, Eric
- Ménard, Didier
- SpringerLink (Online service)
Ähnliche Objekte (12)
Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization
Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand
Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs
Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China–Myanmar, Thailand–Myanmar, and Thailand–Cambodia borders
Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum
In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum
Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine
Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine
Artenimol–piperaquine in children with uncomplicated imported falciparum malaria: experience from a prospective cohort
Plasmepsin II–III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum
Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area
In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene
Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization
Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand
Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs
Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China–Myanmar, Thailand–Myanmar, and Thailand–Cambodia borders
Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum
In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum
Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine
Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine
Artenimol–piperaquine in children with uncomplicated imported falciparum malaria: experience from a prospective cohort
Plasmepsin II–III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum
Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area
In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene
Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization
Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand
Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs
Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China–Myanmar, Thailand–Myanmar, and Thailand–Cambodia borders
Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum
In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum
Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine
Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine
Artenimol–piperaquine in children with uncomplicated imported falciparum malaria: experience from a prospective cohort
Plasmepsin II–III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum
Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area